|
LBRX LB Pharmaceuticals Inc 1691082 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-19,054,000.00 |
| Balance Sheet |
|
Current Assets
|
$389,074,000.00 |
|
Assets
|
$393,482,000.00 |
|
Current Liabilities
|
$10,906,000.00 |
|
Liabilities
|
$14,789,000.00 |
|
Equity
|
$378,693,000.00 |
|
Shares Out
|
28674827.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-23,290,000.00 |
|
Investing Cash Flow
|
$-32,000.00 |
| Market Analysis |
Market Cap
|
$1,172,800,424.30 |
|
Price
|
$41.71 |
|
BVPS
|
13.21 |
|
PB
|
3.10 |
|
EPS
|
-0.67 |
|
FCF
|
$-23,322,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:26 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:22 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-12 |
-0.67 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LBRX documents filed with the SEC.
LBRX Filings
Clear
